Literature DB >> 26036474

The Ins and Outs of Small GTPase Rac1 in the Vasculature.

Goran Marinković1, Niels Heemskerk1, Jaap D van Buul1, Vivian de Waard2.   

Abstract

The Rho family of small GTPases forms a 20-member family within the Ras superfamily of GTP-dependent enzymes that are activated by a variety of extracellular signals. The most well known Rho family members are RhoA (Ras homolog gene family, member A), Cdc42 (cell division control protein 42), and Rac1 (Ras-related C3 botulinum toxin substrate 1), which affect intracellular signaling pathways that regulate a plethora of critical cellular functions, such as oxidative stress, cellular contacts, migration, and proliferation. In this review, we describe the current knowledge on the role of GTPase Rac1 in the vasculature. Whereas most recent reviews focus on the role of vascular Rac1 in endothelial cells, in the present review we also highlight the functional involvement of Rac1 in other vascular cells types, namely, smooth muscle cells present in the media and fibroblasts located in the adventitia of the vessel wall. Collectively, this overview shows that Rac1 activity is involved in various functions within one cell type at distinct locations within the cell, and that there are overlapping but also cell type-specific functions in the vasculature. Chronically enhanced Rac1 activity seems to contribute to vascular pathology; however, Rac1 is essential to vascular homeostasis, which makes Rac1 inhibition as a therapeutic option a delicate balancing act.
Copyright © 2015 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26036474     DOI: 10.1124/jpet.115.223610

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  11 in total

1.  Extracellular adenosine-induced Rac1 activation in pulmonary endothelium: Molecular mechanisms and barrier-protective role.

Authors:  Anita Kovacs-Kasa; Kyung Mi Kim; Mary Cherian-Shaw; Stephen M Black; David J Fulton; Alexander D Verin
Journal:  J Cell Physiol       Date:  2018-03-07       Impact factor: 6.384

Review 2.  Regulation of NADPH oxidases in skeletal muscle.

Authors:  Leonardo F Ferreira; Orlando Laitano
Journal:  Free Radic Biol Med       Date:  2016-05-13       Impact factor: 7.376

Review 3.  RACking up ceramide-induced islet β-cell dysfunction.

Authors:  Anjaneyulu Kowluru; Renu A Kowluru
Journal:  Biochem Pharmacol       Date:  2018-04-30       Impact factor: 5.858

Review 4.  Permeability of the Endothelial Barrier: Identifying and Reconciling Controversies.

Authors:  Lena Claesson-Welsh; Elisabetta Dejana; Donald M McDonald
Journal:  Trends Mol Med       Date:  2020-12-10       Impact factor: 11.951

5.  In-vitro analysis of Quantum Molecular Resonance effects on human mesenchymal stromal cells.

Authors:  Sabrina Sella; Valentina Adami; Eliana Amati; Martina Bernardi; Katia Chieregato; Pamela Gatto; Martina Menarin; Alessandro Pozzato; Gianantonio Pozzato; Giuseppe Astori
Journal:  PLoS One       Date:  2018-01-02       Impact factor: 3.240

Review 6.  Prognostic and Clinicopathological Value of Rac1 in Cancer Survival: Evidence from a Meta-Analysis.

Authors:  Shu Lou; Penglai Wang; Jianrong Yang; Junqing Ma; Chao Liu; Meng Zhou
Journal:  J Cancer       Date:  2018-06-23       Impact factor: 4.207

Review 7.  RhoGTPase in Vascular Disease.

Authors:  Derek Strassheim; Evgenia Gerasimovskaya; David Irwin; Edward C Dempsey; Kurt Stenmark; Vijaya Karoor
Journal:  Cells       Date:  2019-06-06       Impact factor: 6.600

8.  CSN5 inhibition triggers inflammatory signaling and Rho/ROCK-dependent loss of endothelial integrity.

Authors:  Jisca Majolée; Manon C A Pronk; Kin K Jim; Jan S M van Bezu; Astrid M van der Sar; Peter L Hordijk; Igor Kovačević
Journal:  Sci Rep       Date:  2019-05-31       Impact factor: 4.379

Review 9.  The Potential Beneficial Effects of Resveratrol on Cardiovascular Complications in Marfan Syndrome Patients⁻Insights from Rodent-Based Animal Studies.

Authors:  Mitzi M van Andel; Maarten Groenink; Aeilko H Zwinderman; Barbara J M Mulder; Vivian de Waard
Journal:  Int J Mol Sci       Date:  2019-03-05       Impact factor: 5.923

10.  Increased aerobic glycolysis is important for the motility of activated VSMC and inhibited by indirubin-3'-monoxime.

Authors:  Elke H Heiss; Daniel Schachner; Maddalena Donati; Christoph S Grojer; Verena M Dirsch
Journal:  Vascul Pharmacol       Date:  2016-05-14       Impact factor: 5.773

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.